A medication pump with potential to cause more problems than it cures.
Contact Us Now

For a free, confidential
assessment

CareFusion Alaris Pump 8100 Injury Lawsuit

The U.S. Food and Drug Administration (FDA) has announced the recall of an infusion pump manufactured by CareFusion called the Alaris Pump Module, Model 8100.

What Is the CareFusion Alaris Pump 8100?

An infusion pump is a medical device that regularly injects controlled quantities of medications into patients intravenously, intra-arterially, or as an epidural. They can be used on patients of any age.

The Alaris Pump 8100 Might Cause Serious Injury and Death

Keyboard Overlay

On July 20, 2012, CareFusion sent a letter to customers informing them that the Alaris Pump 8100’s keypad overlay could loosen, peel away, or separate from the keypad door assembly. If this occurs, it’s possible that liquid medication could find its way into the keypad and cause a malfunction, which stops the infusion pump and triggers an alarm. For some patients, not receiving regular injections of medication can result in severe injury or death.

Motor Stalls

Also on July 20, 2012, CareFusion sent another letter to customers notifying them that it had received reports that the Alaris Pump 8100 could suffer motor stalls when operating at high infusion speeds. Most such motor stalls occurred at 900 mL/hr, but both CareFusion and the FDA are concerned that they could occur at lower speeds.

If an infusion pump suffers a motor stall, the device stops delivering medication to patients. Some patients with serious medical conditions might not receive life-saving treatment possibly resulting in serious injuries or death. According to the FDA, when a motor stall occurs, the Alaris Pump 8100 will display the error code “242.4030” and sound an alarm.

The FDA classifies both recalls as Class I, the most serious kind, because there is “a reasonable probability that use of the product will cause serious adverse health consequences or death.” The FDA also provides a link to CareFusion’s list of serial numbers for consumers to see if theirs is affected by motor stalls.

Air Embolism

In November 2012, CareFusion announced that postmarket studies showed that the Alaris Pump 8100 could also cause pulmonary embolism because tiny air bubbles might pass undetected into patients’ bodies. Air bubbles in the circulatory system can be deadly because they can cause blockages in blood vessels. Patients with an atrial septal defect are at greater risk.

RLG’s Lawyers Will Make Things Easier

The process of demanding compensation for the harm you’ve suffered can be complicated, even if it doesn’t seem fair that you should have to go through even more trouble to be made whole again. The lawyers at the Rottenstein Law Group believe that obtaining legal satisfaction from those who harmed you shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file a CareFusion Alaris Pump 8100 lawsuit on your behalf if necessary.

If you used an Alaris Pump 8100 and believe it harmed you, contact RLG today.

Join the Discussion

Please note: Comments are encouraged in order to permit visitors to discuss relevant topics. Comments are moderated and might be edited by RLG before being published.

Comments should not be used to ask questions of RLG’s lawyers; if you want to speak with a lawyer, please fill out this contact form or call 1 (888) 976-8529. *Your name and email address will not be published.

*

  


× two = 6

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.